Zobrazeno 1 - 10
of 575
pro vyhledávání: '"C. Harvengt"'
Publikováno v:
Liver. 12:344-350
The cytochrome P-450 3A family is involved in the metabolism of several drugs, including nifedipine, cyclosporine, quinidine and erythromycin. The purpose of this study was to develop a reliable method to obtain a relative quantification of cytochrom
Publikováno v:
Atherosclerosis. 124:S65-S73
The activities of lipoprotein lipase (LPL) and hepatic lipase (HL) were investigated after 23 days of ciprofibrate (100 mg or 200 mg) therapy or fenofibrate (200 mg) therapy. In a double-blind, double-placebo, cross-over study, three groups of six he
Publikováno v:
Acta Clinica Belgica. 49:321-324
Autor:
C. Harvengt
Publikováno v:
Acta Clinica Belgica. 49:42-46
Publikováno v:
Clinical Pharmacology and Therapeutics. 53:431-435
The pharmacokinetics of the second-generation H1-receptor antagonist cetirizine was studied in eight children younger than 4 years of age who were treated with a single dose of cetirizine solution (5 mg). These children were hospitalized with suspect
Autor:
C. Harvengt
Publikováno v:
Acta Clinica Belgica. 48:284-287
Publikováno v:
The Journal of Clinical Pharmacology. 32:422-426
The occurrence of clinical and biochemical side effects of bezafibrate (400 mg daily) or simvastatin (20 mg daily) alone or combined was appraised in 13 healthy male normolipidemic subjects according to a single blind design. Each period of 2 weeks o
Autor:
C. Harvengt
Publikováno v:
Acta Clinica Belgica. 47:217-222
Autor:
C. Harvengt
Publikováno v:
Acta Clinica Belgica. 47:285-289
Autor:
C. Harvengt
Publikováno v:
Acta Clinica Belgica. 47:67-71